PALOMAR MEDICAL TECHNOLOGIES INC
DFAN14A, 1999-06-25
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: FRANKLIN MUNICIPAL SECURITIES TRUST, 497, 1999-06-25
Next: GILEAD SCIENCES INC, DEFM14A, 1999-06-25




       As filed, via EDGAR, with the Securities and Exchange Commission on
                                 June 18, 1999.

                                  SCHEDULE 14A
                                 (Rule 14a-101)
                     INFORMATION REQUIRED IN PROXY STATEMENT
                            SCHEDULE 14A INFORMATION
                Proxy Statement Pursuant to Section 14(a) of the
                         Securities Exchange Act of 1934

      Filed by the registrant  [_]

      Filed by a party other than the registrant [X]

      Check the appropriate box:

     [_]  Preliminary proxy statement

     [_]  Confidential, for Use of the Commission Only (as permitted by Rule
          14a-6(e)(2)

     [_]  Definitive proxy statement

     [_]  Definitive additional materials

     [X]  Soliciting material pursuant to Rule 14a-11(c) or Rule 14a-12


                       PALOMAR MEDICAL TECHNOLOGIES, INC.
                (Name of Registrant as Specified in Its Charter)

  THE MONTEREY STOCKHOLDERS GROUP LLC, MARK T. SMITH, THE ROCKSIDE FOUNDATION,
             LOGG INVESTMENT RESEARCH, INC., THOMAS O'BRIEN and THE
                          R. TEMPLETON SMITH FOUNDATION
    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)


Payment of filing fee (Check the appropriate box):


     [X]  No fee required.

     [_]  Fee  computed on table below per Exchange  Act Rules  14a-6(i)(1)  and
          0-11.

          (1)  Title of each class of securities to which transaction applies:

          (2)  Aggregate number of securities to which transaction applies:

          (3)  Per unit price or other underlying value of transaction  computed
               pursuant to Exchange Act Rule 0-11:

          (4)  Proposed maximum aggregate value of transaction:

          (5)  Total fee paid:

     [_]  Fee paid previously with preliminary materials.

     [_]  Check box if any part of the fee is offset as provided by Exchange Act
          Rule  0-11(a)(2)  and identify the filing for which the offsetting fee
          was paid  previously.  Identify  the previous  filing by  registration
          statement number, or the form or schedule and the date of its filing.

          (1)  Amount previously paid:

          (2)  Form, schedule or registration statement no.:

          (3)  Filing party:

          (4)  Date filed:

<PAGE>


                      MONTEREY STOCKHOLDERS GROUP COMMENTS
                     ON VOTING AT JUNE 23 ANNUAL MEETING OF
                          PALOMAR MEDICAL TECHNOLOGIES

     The Monterey Stockholders Group LLC and Palomar Medical Technologies, Inc.
are awaiting the report of the inspectors of election for the Company's annual
meeting of stockholders that was convened on June 23, 1999. Based upon
information presently available to it, Monterey does not believe that a quorum
required for the conduct of business was present at the meeting.

     Monterey believes that the number of shares cast in favor of management's
nominees at the meeting was substantially less than a majority of the
outstanding shares, although it appeared that they exceeded the votes that
Monterey was able to obtain in the limited time available to it in advance of
the meeting. The shares for which Monterey received proxies were voted at the
meeting. However, members of Monterey were not present at the meeting with
respect to their own shares, which amount to approximately 12% of the
outstanding shares. Monterey took this action in order to bring about an
adjournment of the meeting, thus allowing more time for stockholders to vote
their proxies. Monterey believes that this will result in a more meaningful
stockholder vote on the important issues that distinguish Monterey's plan for
the Company from management's plan. Monterey believes that it would obtain
additional proxies in favor of its nominees with an extended solicitation
period, as it had only a very brief period of less than two weeks in advance of
the meeting to obtain proxies.

     At the annual meeting, the chairman announced that the meeting would be
adjourned until July 1, 1999, and at that time the inspectors of election will
present their tabulation of the votes. Assuming no quorum was present, Monterey
understands the Company's by-laws to provide that the meeting may be adjourned
until the required quorum is in attendance. Monterey urges the Company to
convene the adjourned meeting after a reasonable period for additional
solicitation of proxies to be voted at the meeting.




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission